As of 2025-04-23, the Relative Valuation of Transmedics Group Inc (TMDX) is 44.00 USD. This relative valuation is based on P/E multiples. With the latest stock price at 91.21 USD, the upside of Transmedics Group Inc based on Relative Valuation is -51.8%.
The range of the Relative Valuation is 37.59 - 51.65 USD.
| Range | Selected | |
| Trailing P/E multiples | 35.9x - 43.2x | 38.5x |
| Forward P/E multiples | 32.6x - 37.1x | 34.2x |
| Fair Price | 37.59 - 51.65 | 44.00 |
| Upside | -58.8% - -43.4% | -51.8% |
| Date | P/E |
| 2025-04-17 | 84.17 |
| 2025-04-16 | 81.45 |
| 2025-04-15 | 83.16 |
| 2025-04-14 | 82.84 |
| 2025-04-11 | 76.87 |
| 2025-04-10 | 72.85 |
| 2025-04-09 | 71.94 |
| 2025-04-08 | 64.82 |
| 2025-04-07 | 65.96 |
| 2025-04-04 | 64.55 |
| 2025-04-03 | 67.69 |
| 2025-04-02 | 69.74 |
| 2025-04-01 | 65.12 |
| 2025-03-31 | 64.18 |
| 2025-03-28 | 65.42 |
| 2025-03-27 | 67.19 |
| 2025-03-26 | 67.08 |
| 2025-03-25 | 67.53 |
| 2025-03-24 | 68.18 |
| 2025-03-21 | 65.87 |
| 2025-03-20 | 65.67 |
| 2025-03-19 | 67.09 |
| 2025-03-18 | 65.81 |
| 2025-03-17 | 64.57 |
| 2025-03-14 | 65.37 |
| 2025-03-13 | 61.39 |
| 2025-03-12 | 63.99 |
| 2025-03-11 | 64.53 |
| 2025-03-10 | 62.99 |
| 2025-03-07 | 64.35 |
| 2025-03-06 | 62.28 |
| 2025-03-05 | 64.33 |
| 2025-03-04 | 65.93 |
| 2025-03-03 | 66.14 |
| 2025-02-28 | 72.80 |
| 2025-02-27 | 68.80 |
| 2025-02-26 | 70.36 |
| 2025-02-25 | 69.64 |
| 2025-02-24 | 73.57 |
| 2025-02-21 | 68.63 |
| 2025-02-20 | 71.97 |
| 2025-02-19 | 75.76 |
| 2025-02-18 | 71.56 |
| 2025-02-14 | 68.85 |
| 2025-02-13 | 67.94 |
| 2025-02-12 | 66.32 |
| 2025-02-11 | 64.97 |
| 2025-02-10 | 67.00 |
| 2025-02-07 | 69.25 |
| 2025-02-06 | 70.11 |